PARK AVENUE SECURITIES LLC
Broker-DealerPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1071640
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$974,593
-$319,579 QoQ
Shares Held
1,563
-6.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#651
of 1,322 holders
Holding Since
Sep 2020
22 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $18,019,918 across 22 Biotechnology names. REGN ranks #4 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,198 | $5,065,652 | |
| 2 | RPRX |
Royalty Pharma plc
|
46,965 | $2,633,327 | |
| 3 | INSM |
INSMED Inc
|
9,927 | $1,058,416 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,563 | $974,593 | |
| 5 | EXEL |
Exelixis, Inc.
|
16,542 | $900,050 | |
| 6 | ARGX |
Argenx SE
|
956 | $886,948 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
3,608 | $869,419 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
10,089 | $789,666 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $974,593 | 1,563 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,294,172 | 1,675 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,247,341 | 1,616 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $881,077 | 1,567 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $771,225 | 1,469 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $938,660 | 1,480 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,438,194 | 2,019 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,985,792 | 1,889 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $1,844,557 | 1,755 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,608,320 | 1,671 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,343,783 | 1,530 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,176,009 | 1,429 | Shares | Sole | 2023-10-26 | |
| 2022-12-31 | $801,575 | 1,111 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $721,246 | 1,047 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $580,489 | 982 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $600,641 | 860 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,033,798 | 1,637 | Shares | Sole | 2022-04-08 | |
| 2021-09-30 | $416,969 | 689 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $521,117 | 933 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $523,292 | 1,106 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $333,829 | 691 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $216,075 | 386 | Shares | Sole | 2020-11-03 | |
| No filing history on record for this holder in this stock. | ||||||